ArticleTargeted oncology2023

Impact of KRAS Mutations on Clinical Outcomes of Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer Receiving Anti-PD-1/PD-L1 Therapy.

Antonello Veccia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.